Key result
Propafenone plus beta-blocker therapy suppresses bidirectional VT and reduces ventricular arrhythmic load by ~20 percentage points.
Why the study?
Bidirectional ventricular tachycardia is a rare ECG finding associated with hereditary channelopathies, requiring early recognition and targeted genetic investigation to prevent arrhythmia-induced cardiomyopathy.
Does the combination of propafenone and a beta-blocker suppress bidirectional ventricular tachycardia and reduce arrhythmic burden in Andersen-Tawil syndrome?
Case Report (n=1)
No
Does the combination of propafenone and a beta-blocker suppress bidirectional ventricular tachycardia and reduce arrhythmic burden in Andersen-Tawil syndrome?
Propafenone combined with a beta-blocker may be an effective therapeutic alternative to flecainide for suppressing bidirectional ventricular tachycardia and reversing tachycardiomyopathy in Andersen-Tawil syndrome.
Answers are grounded in this paper and cite their sources.
Propafenone plus beta-blocker may suppress bidirectional VT in Andersen-Tawil syndrome; hypothesis-generating and requires prospective validation.
BACKGROUND: Bidirectional ventricular tachycardia is a rare electrocardiographic (ECG) finding, associated with a restricted group of clinical conditions, particularly hereditary channelopathies. CASE SUMMARY: An 11-year-old girl, asymptomatic from a cardiovascular point of view, was identified by family screening after detection in her father of a pathogenic variant in the KCNJ2 gene. The admission ECG showed bidirectional ventricular tachycardia. Clinical investigation revealed periodic paralysis and skeletal dysmorphisms, confirming a diagnosis of Andersen-Tawil syndrome. Pharmacological treatment significantly reduced the arrhythmic burden, with reverse ventricular remodeling at follow-up. DISCUSSION: This case illustrates the central role of ECG as a diagnostic tool in rare cardiovascular diseases, allowing early recognition, targeted genetic investigation, and prevention of arrhythmia-induced cardiomyopathy. TAKE HOME MESSAGES: Bidirectional ventricular tachycardia is a distinct ECG pattern that should raise suspicion of Andersen-Tawil syndrome and warrants genetic evaluation with cascade family screening. In this patient, the combination of propafenone and beta-blocker therapy was associated with suppression of bidirectional ventricular tachycardia, significant reduction in ventricular arrhythmic load, and reversal of tachycardiomyopathy, suggesting a potential therapeutic alternative when flecainide is not available.
No takes yet. Share an insight, caveat, or question.
Assunção et al. (2026) conducted a case report in Andersen-Tawil syndrome with bidirectional ventricular tachycardia (n=1). Combination of propafenone and beta-blocker (propranolol) was evaluated on Reduction of ventricular arrhythmic load. The combination of propafenone and beta-blocker therapy completely suppressed bidirectional ventricular tachycardia, reduced ventricular arrhythmic load from 59% to 39%, and reversed incipient tachycardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: